GKB Ophthalmics
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
July 14 (Reuters) - GKB Ophthalmics Ltd GKBO.BO:
GKB OPHTHALMICS - GETS NOTICE OF DEMAND FROM LABOUR COMMISSIONER FOR RECOVERY OF 88.2 MILLION RUPEES ON JULY 13, 2026
Source text: ID:nBSEJbM2t
Further company coverage: GKBO.BO
(([email protected];;))
July 14 (Reuters) - GKB Ophthalmics Ltd GKBO.BO:
GKB OPHTHALMICS - GETS NOTICE OF DEMAND FROM LABOUR COMMISSIONER FOR RECOVERY OF 88.2 MILLION RUPEES ON JULY 13, 2026
Source text: ID:nBSEJbM2t
Further company coverage: GKBO.BO
(([email protected];;))
Jan 3 (Reuters) - GKB Ophthalmics Ltd GKBO.BO:
APPROVES UNSECURED LOAN OF UPTO 50 MILLION RUPEES
Source text: ID:nBSE3Qdp19
Further company coverage: GKBO.BO
(([email protected];;))
Jan 3 (Reuters) - GKB Ophthalmics Ltd GKBO.BO:
APPROVES UNSECURED LOAN OF UPTO 50 MILLION RUPEES
Source text: ID:nBSE3Qdp19
Further company coverage: GKBO.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does GKB Ophthalmics do?
Established in 1981, GKB Ophthalmics is a public listed company specialized in manufacturing single vision, bifocal, and progressive lenses for export to global markets.
Who are the competitors of GKB Ophthalmics?
GKB Ophthalmics major competitors are Centenial Surg. Sut., Galaxy Medicare, Kretto Syscon, KMS Medisurgi, Amkay Products, Transpact Enterprise, Boston Commerce. Market Cap of GKB Ophthalmics is ₹29 Crs. While the median market cap of its peers are ₹30 Crs.
Is GKB Ophthalmics financially stable compared to its competitors?
GKB Ophthalmics seems to be less financially stable compared to its competitors. Altman Z score of GKB Ophthalmics is 2.26 and is ranked 6 out of its 8 competitors.
Does GKB Ophthalmics pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. GKB Ophthalmics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has GKB Ophthalmics allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances
How strong is GKB Ophthalmics balance sheet?
Balance sheet of GKB Ophthalmics is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of GKB Ophthalmics improving?
The profit is oscillating. The profit of GKB Ophthalmics is ₹3.08 Crs for TTM, -₹7.04 Crs for Mar 2025 and -₹2.81 Crs for Mar 2024.
Is the debt of GKB Ophthalmics increasing or decreasing?
Yes, The net debt of GKB Ophthalmics is increasing. Latest net debt of GKB Ophthalmics is ₹6.76 Crs as of Mar-26. This is greater than Mar-25 when it was -₹13.09 Crs.
Is GKB Ophthalmics stock expensive?
GKB Ophthalmics is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of GKB Ophthalmics is 24.21, while 3 year average PE is 9.71. Also latest EV/EBITDA of GKB Ophthalmics is 4.3 while 3yr average is 81.78.
Has the share price of GKB Ophthalmics grown faster than its competition?
GKB Ophthalmics has given better returns compared to its competitors. GKB Ophthalmics has grown at ~-18.8% over the last 2yrs while peers have grown at a median rate of -21.0%
Is the promoter bullish about GKB Ophthalmics?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 51.15% and last quarter promoter holding is 51.13%.
Are mutual funds buying/selling GKB Ophthalmics?
There is Insufficient data to gauge this.